Evolent Health, Inc.
EVH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $964,998 | $1,304,831 | $1,092,033 | $1,294,110 |
| - Cash | $116,650 | $150,995 | $246,547 | $104,203 |
| + Debt | $27,493 | $204,738 | $870,097 | $713,673 |
| Enterprise Value | $875,841 | $1,358,574 | $1,715,583 | $1,903,580 |
| Revenue | $479,533 | $444,328 | $483,649 | $646,542 |
| % Growth | 7.9% | -8.1% | -25.2% | – |
| Gross Profit | $99,774 | $100,385 | $102,471 | $75,711 |
| % Margin | 20.8% | 22.6% | 21.2% | 11.7% |
| EBITDA | $14,532 | $12,771 | -$28,705 | $13,287 |
| % Margin | 3% | 2.9% | -5.9% | 2.1% |
| Net Income | -$20,864 | -$19,897 | -$64,618 | -$22,802 |
| % Margin | -4.4% | -4.5% | -13.4% | -3.5% |
| EPS Diluted | -0.24 | -0.44 | -0.63 | -0.27 |
| % Growth | 45.5% | 30.2% | -133.3% | – |
| Operating Cash Flow | $15,812 | -$30,334 | $4,565 | -$26,231 |
| Capital Expenditures | -$8,962 | -$8,770 | -$8,595 | -$6,151 |
| Free Cash Flow | $6,850 | -$39,104 | -$4,030 | -$32,382 |